NEW YORK (GenomeWeb) – Bayer and Leica Biosystems said today they will collaborate on the development of a companion diagnostic that employs immunohistochemistry and RNAscope, a multiplex nucleic acid hybridization technology, to test cancer tissue.

Financial terms of the agreement were not disclosed.

Under the terms of the deal, Leica will provide expertise in assay development, regulatory approval, and commercialization of companion diagnostic tests for targeted anticancer therapies developed by Bayer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.